Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-42400-5
L
Lena Weiss
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
279
Citations
9
h-index
8
i10-index
Lena Weiss is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 9, co-authored 51 publications.
ORCID: 0000-0002-8101-3529Papers by this author
worksEfficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
2022 · ESMO Open · 17 citations
https://doi.org/10.1016/j.esmoop.2022.100391
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
2023 · Targeted Oncology · 17 citations
https://doi.org/10.1007/s11523-023-00950-0
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
2023 · Targeted Oncology · 14 citations
https://doi.org/10.1007/s11523-023-00985-3
Smoking as a risk factor for colorectal neoplasms in young individuals? A systematic meta-analysis
2023 · International Journal of Colorectal Disease · 11 citations
https://doi.org/10.1007/s00384-023-04405-w
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
2024 · European Journal of Cancer · 9 citations
https://doi.org/10.1016/j.ejca.2024.113926
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat